Medical Research and Clinical Trials

Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors

• Medical Research and Clinical Trials

Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors

Asep Darmawan July 25, 2026

A pivotal Phase I clinical trial has commenced, marking a significant step forward in the development of...

Read More Read more about Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors

Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

• Medical Research and Clinical Trials

Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Pevita Pearce July 25, 2026

LA JOLLA, CA – May 12, 2025 – In a landmark study poised to redefine our understanding...

Read More Read more about Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

• Medical Research and Clinical Trials

Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

Rifan Muazin July 25, 2026

New Phase III data from the MonumenTAL-6 study heralds a potential paradigm shift in multiple myeloma therapy,...

Read More Read more about Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

Landmark Patient Recruitment Milestone Achieved for Nizubaglustat in Rare Neurological Disorders

• Medical Research and Clinical Trials

Landmark Patient Recruitment Milestone Achieved for Nizubaglustat in Rare Neurological Disorders

Neng Nana July 25, 2026

Azafaros announces completion of enrollment for pivotal Phase III trial in GM1/GM2 Gangliosidoses, marking a significant stride...

Read More Read more about Landmark Patient Recruitment Milestone Achieved for Nizubaglustat in Rare Neurological Disorders

Cambridge Breakthrough Offers Hope for Aggressive Inherited Breast Cancers: 100% Survival Achieved in Groundbreaking Trial

• Medical Research and Clinical Trials

Cambridge Breakthrough Offers Hope for Aggressive Inherited Breast Cancers: 100% Survival Achieved in Groundbreaking Trial

Asro July 25, 2026

Cambridge, UK – In a development poised to redefine the treatment landscape for aggressive, inherited breast cancers,...

Read More Read more about Cambridge Breakthrough Offers Hope for Aggressive Inherited Breast Cancers: 100% Survival Achieved in Groundbreaking Trial

Breakthrough in Pediatric Pneumonia Treatment: Early Switch to Oral Antibiotics Proven Safe and Effective, Reducing Hospital Stays

• Medical Research and Clinical Trials

Breakthrough in Pediatric Pneumonia Treatment: Early Switch to Oral Antibiotics Proven Safe and Effective, Reducing Hospital Stays

Basiran July 25, 2026

A groundbreaking clinical trial has demonstrated that children hospitalized with severe pneumonia can safely transition from injectable...

Read More Read more about Breakthrough in Pediatric Pneumonia Treatment: Early Switch to Oral Antibiotics Proven Safe and Effective, Reducing Hospital Stays

Breakthrough in Brain Tumour Diagnosis Promises Rapid Answers and Lifesaving Care

• Medical Research and Clinical Trials

Breakthrough in Brain Tumour Diagnosis Promises Rapid Answers and Lifesaving Care

Asep Darmawan July 24, 2026

Nottingham, UK – A revolutionary new method for genetically diagnosing brain tumours, developed by scientists and clinicians...

Read More Read more about Breakthrough in Brain Tumour Diagnosis Promises Rapid Answers and Lifesaving Care

China Ascends as Oncology Clinical Trial Powerhouse, Reshaping Global Drug Development Landscape

• Medical Research and Clinical Trials

China Ascends as Oncology Clinical Trial Powerhouse, Reshaping Global Drug Development Landscape

Suro Senen July 24, 2026

The once-dominant United States is rapidly ceding ground in the critical field of oncology clinical trials, with...

Read More Read more about China Ascends as Oncology Clinical Trial Powerhouse, Reshaping Global Drug Development Landscape

Unraveling the Silent Threat: Genetics and Treatment Converge in Secondary Cancer Risk for Childhood Cancer Survivors

• Medical Research and Clinical Trials

Unraveling the Silent Threat: Genetics and Treatment Converge in Secondary Cancer Risk for Childhood Cancer Survivors

Layla Zulfa July 24, 2026

Memphis, TN – [Current Date] – A groundbreaking study from St. Jude Children’s Research Hospital has fundamentally...

Read More Read more about Unraveling the Silent Threat: Genetics and Treatment Converge in Secondary Cancer Risk for Childhood Cancer Survivors

A Paradigm Shift in Understanding Tumour Growth: New Research Challenges Decades-Old Beliefs in NF-1

• Medical Research and Clinical Trials

A Paradigm Shift in Understanding Tumour Growth: New Research Challenges Decades-Old Beliefs in NF-1

Evan Lee Salim July 24, 2026

Cambridge, UK – February 25, 2024 – In a significant breakthrough poised to redefine the understanding of...

Read More Read more about A Paradigm Shift in Understanding Tumour Growth: New Research Challenges Decades-Old Beliefs in NF-1